Is extending the Early Warrant Exercise Incentive Program for its 6.4 million outstanding and unlisted share purchase warrants having an exercise price of $1.50 and expiring on July 31, 2024. Antibe Therapeutics Inc. shares T.ATE are trading unchanged at $1.01.
Stocks in play: Antibe Therapeutics Inc.
Baystreet.ca - Baystreet - Contributor Content
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here
/Technology%20abstract%20by%20TU%20IS%20via%20iStock.jpg)